Search Press releases Keywords From To 21 Aug 2020 Disposals of own shares Read More 10 Aug 2020 Acquisitions and disposals of own shares Read More 5 Aug 2020 CIMZIA[®] is the First and Only Biologic Approved in Europe with the Option for a Reduced Maintenance Dose for Patients Across the Full Axial Spondyloarthritis Spectrum Read More 30 Jul 2020 Acquisitions and disposals of own shares Read More 30 Jul 2020 Transparency notification FMR LLC. Read More 29 Jul 2020 UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer’s Disease Read More Pagination First page Previous page Previous … Page 57 Page 58 Page 59 Page 60 Current page 61 Page 62 Page 63 Page 64 Page 65 … Page 61 of 69 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
